Have a personal or library account? Click to login
Type 3 VWD and an inhibitor to VWF: Challenges in diagnosis Cover

Type 3 VWD and an inhibitor to VWF: Challenges in diagnosis

The Journal of Haemophilia Practice
Volume 3 (2016): Issue 2 (July 2016)
By: S. Jenkins,  Manuel Carcao and  Vanessa Bouskill  
Open Access
|Apr 2018

Authors

S. Jenkins

Lawrence Bloomberg Faculty of Nursing, University of Toronto,, Toronto, Canada

Manuel Carcao

Department of Paediatrics, Division of Haematology/ Oncology, and Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, University of Toronto,, Toronto, Canada

Vanessa Bouskill

vanessa.bouskill@sickkids.ca

Department of Paediatrics, Division of Haematology/ Oncology, and Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, University of Toronto,, Toronto, Canada
DOI: https://doi.org/10.17225/jhp00068 | Journal eISSN: 2055-3390
Journal RSS Feed
Language: English
Page range: 1 - 3
Published on: Apr 21, 2018
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
children,
Type 3 von Willebrand disease,
VWF inhibitor
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other,
Pharmacy,
Pharmacology

© 2018 S. Jenkins, Manuel Carcao, Vanessa Bouskill, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 3 (2016): Issue 2 (July 2016)Next article